y 27632 has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakaki, K; Chiba, S; Kato, S; Lin, Y; Matayoshi, S; Matsumoto, H; Nakanishi, T; Suzuki, M | 1 |
Chen, CL; Chen, HC; Tsai, WC | 1 |
2 other study(ies) available for y 27632 and Squamous Cell Carcinoma of Head and Neck
Article | Year |
---|---|
Lysophosphatidic acid receptor 4 signaling potentially modulates malignant behavior in human head and neck squamous cell carcinoma cells.
Topics: Amides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Pyridines; Receptors, Purinergic P2; Signal Transduction; Squamous Cell Carcinoma of Head and Neck | 2013 |
Protein tyrosine phosphatase SHP2 promotes invadopodia formation through suppression of Rho signaling.
Topics: ADP Ribose Transferases; Amides; Botulinum Toxins; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Oligopeptides; Podosomes; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; RNA Interference; RNA, Small Interfering; Signal Transduction; Squamous Cell Carcinoma of Head and Neck | 2015 |